The IN-MIDAZ study - Intranasal midazolam in aborting seizures - An epilepsy monitoring unit based randomized controlled trial for efficacy.

Shaikh, Raja Gulfam; Ramanujan, Bhargavi; Singh, Rajesh Kumar; Vibha, Deepti; Mehta, Santosh; Appukuttan, Renjith; Tripathi, Manjari

Shaikh, Raja Gulfam; Ramanujan, Bhargavi; Singh, Rajesh Kumar; Vibha, Deepti; Mehta, Santosh; Appukuttan, Renjith; Tripathi, Manjari.

Afiliação

Shaikh RG; Department of Neurology, Super Speciality Hospital, MGM Medical College, Indore, India.
Ramanujan B; Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Singh RK; Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Vibha D; Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Mehta S; All India Institute of Medical Sciences, New Delhi, India.
Appukuttan R; All India Institute of Medical Sciences, New Delhi, India.
Tripathi M; All India Institute of Medical Sciences, New Delhi, India. Electronic address: mantriaiims@gmail.com.

Epilepsy Res ; 188: 107037, 2022 12.

Article em En | MEDLINE | ID: mdl-36332541

Assuntos

Epilepsia Resistente a Medicamentos; Estado Epiléptico; Criança; Adulto; Humanos; Midazolam/uso terapêutico; Midazolam/efeitos adversos; Anticonvulsivantes/efeitos adversos; Convulsões/tratamento farmacológico; Convulsões/induzido quimicamente; Estado Epiléptico/tratamento farmacológico; Administração Intranasal; Epilepsia Resistente a Medicamentos/tratamento farmacológico

Palavras-chave

Antiepileptic drugs; EMU; Epilepsy; Intranasal; Midazolam; VEEG

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Epiléptico / Epilepsia Resistente a Medicamentos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google